SEC Form 3 · accession 0001415889-18-000645
CELGENE CORP /DE/ · CELG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hans Edgar Bishop
Director
Period of report
Apr 18, 2018
Accepted (ET)
Apr 19, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 23,088 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $91.01 | holding | — | — | — | Apr 18, 2018 | Apr 18, 2028 | Common Stock | 10,000 | — | D |
Explanation of responses
- F1Stock options granted pursuant to the Celgene Corporation 2017 Stock Incentive Plan, are immediately exercisable and will vest in four equal installments commencing on April 18, 2019.